These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34219712)

  • 21. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
    Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
    Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    Atwood CS; Bowen RL
    J Alzheimers Dis; 2015; 47(1):33-47. PubMed ID: 26402752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
    Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
    J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.
    Dodson SE; Andersen OM; Karmali V; Fritz JJ; Cheng D; Peng J; Levey AI; Willnow TE; Lah JJ
    J Neurosci; 2008 Nov; 28(48):12877-86. PubMed ID: 19036982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.
    Bu XL; Xiang Y; Jin WS; Wang J; Shen LL; Huang ZL; Zhang K; Liu YH; Zeng F; Liu JH; Sun HL; Zhuang ZQ; Chen SH; Yao XQ; Giunta B; Shan YC; Tan J; Chen XW; Dong ZF; Zhou HD; Zhou XF; Song W; Wang YJ
    Mol Psychiatry; 2018 Sep; 23(9):1948-1956. PubMed ID: 29086767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Lopes JP; Oliveira CR; Agostinho P
    Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease.
    Song B; Davis K; Liu XS; Lee HG; Smith M; Liu X
    Aging (Albany NY); 2011 Sep; 3(9):846-51. PubMed ID: 21931181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
    Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FAK-Mediated Signaling Controls Amyloid Beta Overload, Learning and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Saleh B; Srikanth KD; Sneh T; Yue L; Pelech S; Elliott E; Gil-Henn H
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel human tau knock-in mouse model reveals interaction of Abeta and human tau under progressing cerebral amyloidosis in 5xFAD mice.
    Barendrecht S; Schreurs A; Geissler S; Sabanov V; Ilse V; Rieckmann V; Eichentopf R; Künemund A; Hietel B; Wussow S; Hoffmann K; Körber-Ferl K; Pandey R; Carter GW; Demuth HU; Holzer M; Roßner S; Schilling S; Preuss C; Balschun D; Cynis H
    Alzheimers Res Ther; 2023 Jan; 15(1):16. PubMed ID: 36641439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathological implications of cell cycle re-entry in Alzheimer disease.
    Bonda DJ; Lee HP; Kudo W; Zhu X; Smith MA; Lee HG
    Expert Rev Mol Med; 2010 Jun; 12():e19. PubMed ID: 20584423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.